{"id":"https://openalex.org/W4362495441","doi":"https://doi.org/10.1158/1535-7163.c.6536557.v1","title":"Data from Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer","display_name":"Data from Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362495441","doi":"https://doi.org/10.1158/1535-7163.c.6536557.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6536557.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536557.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536557.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6536557.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067892203","display_name":"Rebecca A. Previs","orcid":"https://orcid.org/0000-0001-8087-9120","observed_orcids":["https://orcid.org/0000-0001-8087-9120"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca A. Previs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060034442","display_name":"Guillermo N. Armaiz-Pe\u00f1a","orcid":"https://orcid.org/0000-0002-9081-5339","observed_orcids":["https://orcid.org/0000-0002-9081-5339"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo N. Armaiz-Pena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067490446","display_name":"Yvonne Gail Lin","orcid":"https://orcid.org/0000-0002-0888-7182","observed_orcids":["https://orcid.org/0000-0002-0888-7182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yvonne G. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101654792","display_name":"Ashley N. Davis","orcid":"https://orcid.org/0000-0002-0158-9326","observed_orcids":["https://orcid.org/0000-0002-0158-9326"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashley N. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043392987","display_name":"Sunila Pradeep","orcid":"https://orcid.org/0000-0003-2441-7727","observed_orcids":["https://orcid.org/0000-0003-2441-7727"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunila Pradeep","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103775706","display_name":"Heather J. Dalton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather J. Dalton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111144613","display_name":"Jean Marie Hansen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean M. Hansen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039017321","display_name":"William M. Merritt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William M. Merritt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054033791","display_name":"Alpa Manchandia Nick","orcid":"https://orcid.org/0000-0001-9232-1458","observed_orcids":["https://orcid.org/0000-0001-9232-1458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alpa M. Nick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036055459","display_name":"Robert R. Langley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert R. Langley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009234043","display_name":"Robert Louis Coleman","orcid":"https://orcid.org/0000-0001-9343-8754","observed_orcids":["https://orcid.org/0000-0001-9343-8754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Coleman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100640276","display_name":"Anil K. Sood","orcid":"https://orcid.org/0000-0002-5415-9901","observed_orcids":["https://orcid.org/0000-0002-5415-9901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil K. Sood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9660000205039978},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":1.0},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/thrombospondin-1","display_name":"thrombospondin-1","score":0.902999997138977},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-1alpha","display_name":"hypoxia-inducible factor-1\u03b1","score":0.9779999852180481},{"id":"https://openalex.org/keywords/taxane-resistance","display_name":"taxane resistance","score":0.7590000033378601},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.6499999761581421},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.9079999923706055},{"id":"https://openalex.org/keywords/tube-formation","display_name":"tube formation","score":0.703000009059906},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.7319999933242798},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6840000152587891},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.753000020980835},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.7290844917297363},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.727120041847229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7034175395965576},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6400773525238037},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.6319543719291687},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6049489974975586},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5580487847328186},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5434747338294983},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.48475000262260437},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39266565442085266},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38105401396751404},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.37159258127212524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28687405586242676},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.21594354510307312},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10562840104103088},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6536557.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536557.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536557.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6536557.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536557.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536557.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2180173761","https://openalex.org/W2057039030","https://openalex.org/W2006350851","https://openalex.org/W2140640502","https://openalex.org/W4361813555","https://openalex.org/W2318605992","https://openalex.org/W2137268781","https://openalex.org/W4300456638","https://openalex.org/W2130349349","https://openalex.org/W2131560485"],"abstract_inverted_index":{"Abstract":[0],"There":[1],"is":[2],"growing":[3],"recognition":[4],"of":[5,9,18,27,45,66,229],"the":[6,16,25,43,64,115,124,137],"important":[7],"role":[8],"metronomic":[10,40,67,70,97,104,140,180,184,214,222,225,230,233],"chemotherapy":[11],"in":[12,51,85,101,107,110,114,123,169,178,187,191,205],"cancer":[13],"treatment.":[14],"On":[15],"basis":[17],"their":[19],"unique":[20],"antiangiogenic":[21],"effects,":[22],"we":[23],"tested":[24],"efficacy":[26],"nab-paclitaxel,":[28],"which":[29,34],"stimulates":[30],"thrombospondin-1,":[31],"and":[32,50,55,69,80,100,121,174,217,224,232],"topotecan,":[33],"inhibits":[35],"hypoxia-inducible":[36],"factor":[37],"1-\u03b1,":[38],"at":[39,88],"dosing":[41],"for":[42,242],"treatment":[44,95],"ovarian":[46,243],"carcinoma.":[47],"In":[48,90,136],"vitro":[49],"vivo":[52,91,192],"SKOV3ip1,":[53],"HeyA8,":[54],"HeyA8-MDR":[56,138],"(taxane-resistant)":[57],"orthotopic":[58],"models":[59],"were":[60],"used":[61],"to":[62,210],"examine":[63],"effects":[65,148],"nab-paclitaxel":[68,98,215,223,231],"topotecan.":[71,226],"We":[72],"examined":[73],"cell":[74],"proliferation":[75,175],"(Ki-67),":[76],"apoptosis":[77],"(cleaved":[78],"caspase-3),":[79],"angiogenesis":[81],"(microvessel":[82],"density,":[83],"MVD)":[84],"tumors":[86],"obtained":[87],"necropsy.":[89],"therapy":[92,154,181,185],"experiments":[93],"demonstrated":[94],"with":[96,103,131,142,161,194,213,220],"alone":[99,216],"combination":[102,153,179,221,228],"topotecan":[105,234],"resulted":[106,186],"significant":[108],"reductions":[109],"tumor":[111,150,156],"weight":[112],"(62%":[113],"SKOV3ip1":[116],"model,":[117,126,139],"P":[118,127],"<":[119,128,134,164,172,198],"0.01":[120],"96%":[122],"HeyA8":[125],"0.03)":[129],"compared":[130,160,193],"vehicle":[132,162],"(P":[133,163,171,197],"0.01).":[135],"monotherapy":[141],"either":[143],"cytotoxic":[144],"agent":[145],"had":[146],"modest":[147],"on":[149],"growth,":[151],"but":[152],"decreased":[155],"burden":[157],"by":[158],"61%":[159],"0.03).":[165],"The":[166,227],"greatest":[167],"reduction":[168],"MVD":[170],"0.05)":[173],"was":[176,202],"seen":[177],"groups.":[182],"Combination":[183],"prolonged":[188],"overall":[189],"survival":[190],"other":[195],"groups":[196],"0.001).":[199],"Tube":[200],"formation":[201],"significantly":[203],"inhibited":[204],"RF-24":[206],"endothelial":[207],"cells":[208],"exposed":[209],"media":[211,218],"conditioned":[212,219],"offers":[235],"a":[236],"novel,":[237],"highly":[238],"effective":[239],"therapeutic":[240],"approach":[241],"carcinoma":[244],"that":[245],"merits":[246],"further":[247],"clinical":[248],"development.":[249],"Mol":[250],"Cancer":[251],"Ther;":[252],"14(12);":[253],"2677\u201386.":[254],"\u00a92015":[255],"AACR.":[256]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}